Bhustrina (Lemon Grass)

<h3> Absolute Contraindications of Bhustrina (Lemon Grass) </h3> <h4> Pregnancy (especially high-dose or concentrated essential oil use)</h4> <ul> <li> 🤰 <li> Recommendation: Avoid high-dose consumption or concentrated essential oil use during pregnancy; if pregnant and considering use, consult your obstetric provider first and prefer low-dose culinary amounts only. <li> Reasoning: Animal developmental studies with citral (major lemongrass component) show maternal toxicity and fetal growth effects at higher oral doses; safety margins for concentrated oils in humans are uncertain. <li> Scientific_Study_Title: Study on the embryofeto-toxicity of citral in the rat <li> Scientific_Study_Authors: A C Nogueira, R R Carvalho, C A Souza, I Chahoud, F J Paumgartten <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/7886681/ <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: In Wistar rats given citral orally during organogenesis (day 6-15), researchers observed signs of maternal toxicity at several doses and noted fetal growth retardation and a higher incidence of minor skeletal changes at doses above low thresholds. The study concluded that citral produced maternal toxicity across the dose range and that developmental effects (reduced fetal weight, some skeletal alterations and increased post-implantation loss at some doses) occurred at higher exposure levels, indicating a no-observed-adverse-effect level lower than tested low doses.</p> <p>Clinical implication: these animal data do not prove human teratogenicity but show that concentrated citral exposures can affect pregnancy outcomes in mammals, supporting caution with concentrated lemongrass oil or high-dose supplements during pregnancy.</p> </ul> <h4>Known hypersensitivity / contact allergy to lemongrass / citral</h4> <ul> <li> 🚫🧴 <li> Recommendation: Do not use topical lemongrass oil or concentrated products if you have a known allergy to citrus/essential-oil fragrances or prior contact dermatitis to lemongrass/citral; for oral use avoid if prior systemic reactions to these oils occurred. <li> Reasoning: Citral and lemongrass oil contain sensitizing aldehydes (geranial/neral); controlled assays and patient testing document contact allergy rates and sensitization potential. <li> Scientific_Study_Title: Investigation of the dermal sensitization potential of various essential oils in the local lymph node assay <li> Scientific_Study_Authors: J Lalko, A M Api <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/16324777/ <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: Using the validated local lymph node assay, the authors tested multiple essential oils (including lemongrass) and key components (citral) across concentrations and calculated EC3 values (concentration eliciting a positive sensitization response). Lemongrass oil and citral demonstrated measurable sensitization potential (EC3 in a range indicating weak-moderate potency). The paper highlights that lemongrass oil and its aldehyde constituents can act as contact sensitizers in standardized models.</p> <p>Clinical implication: these data support documented clinical patch-test reactions and recommend avoiding topical exposure in sensitized individuals and exercising care when using concentrated products.</p> </ul> <h4>High-dose concentrated essential oil ingestion / intravenous or inappropriate use</h4> <ul> <li> ⚠️ <li> Recommendation: Do not ingest concentrated lemongrass essential oil or apply undiluted oil internally; keep essential oils out of reach of children and avoid non-approved routes of administration. <li> Reasoning: In vitro and model systems show cytotoxicity of essential oil and isolated citral/geraniol to human blood cells and Artemia salina at higher concentrations - suggesting potential for toxicity with inappropriate high-dose use. <li> Scientific_Study_Title: Cytotoxicity of Cymbopogon citratus fractions, essential oil, citral, and geraniol in human leukocytes and erythrocytes <li> Scientific_Study_Authors: Ana Carolina Mendes Hacke, Fernanda D'Avila da Silva, Dhésmon Lima, José Carlos Rebuglio Vellosa, João Batista Teixeira Rocha, Jacqueline Aparecida Marques, Romaiana Picada Pereira <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/35227781/ <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: Laboratory assays showed that C. citratus essential oil and its main constituents (citral, geraniol) had high lethality against Artemia salina and reduced viability of human leukocytes and altered erythrocyte membranes at higher concentrations. Essential oil and isolated compounds produced dose-dependent cytotoxic effects in vitro, while some leaf fractions were less toxic. The authors caution that concentrated preparations exert cellular toxicity in lab models and warrant careful in vivo evaluation.</p> <p>Clinical implication: these in vitro toxicity findings argue against ingestion or internal use of concentrated essential oil and support the safe-use principle of dilution and limited dosing for human exposure.</p> </ul> <h3> Relative Contraindications of Bhustrina (Lemon Grass) </h3> <h4>People on antidiabetic medication (risk of additive hypoglycemia)</h4> <ul> <li> 🩺⚖️ <li> Recommendation: If you take prescription diabetes medications, consult your clinician before adding lemongrass supplements or frequent strong infusions; monitor blood glucose closely if combined. <li> Reasoning: C. citratus flavonoids inhibit α-glucosidase in vitro and lemongrass extracts produced hypoglycemic effects in animal models, which could enhance the action of antidiabetic drugs and lower blood sugar further. <li> Scientific_Study_Title: Inhibition of α-glucosidase by flavonoids of Cymbopogon citratus (DC) Stapf <li> Scientific_Study_Authors: Pedro H O Borges, Sónia Pedreiro, Salete J Baptista, Carlos F G C Geraldes, M T Batista, Maria M C Silva, Artur Figueirinha <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34329713/ <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: The study isolated flavonoids from C. citratus infusion and demonstrated potent inhibition of yeast α-glucosidase in vitro, with some flavone glycosides more active than a reference drug. Molecular docking supported specific interactions in the enzyme pocket. The biochemical data provide a plausible mechanism for observed hypoglycemic activity in prior animal studies.</p> <p>Clinical implication: enzyme inhibition in the gut can blunt carbohydrate absorption and, when combined with glucose-lowering drugs, may increase hypoglycemia risk - hence monitoring and medical supervision are prudent.</p> </ul> <h4>People using antihypertensive / vasodilator drugs (possible additive blood-pressure lowering)</h4> <ul> <li> 💊⬇️ <li> Recommendation: If you are on antihypertensive therapy, discuss lemongrass supplementation with your clinician and monitor blood pressure when starting or changing doses. <li> Reasoning: Extracts and citral show vasorelaxant effects in isolated aorta/vascular tissue studies, suggesting potential to add to the blood-pressure lowering effects of medications. <li> Scientific_Study_Title: Effect of Cymbopogon citratus and Citral on Vascular Smooth Muscle of the Isolated Thoracic Rat Aorta <li> Scientific_Study_Authors: A A Al-Matubsi, S H Obeidat, et al. (authors as listed on PubMed record) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22675383/ <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: In isolated rat aortic rings pre-contracted with phenylephrine, citral and C. citratus extracts produced dose-dependent relaxation; citral’s effect was partially nitric-oxide dependent (attenuated by L-NAME), implicating endothelial/NO pathways. The findings show a direct vascular smooth-muscle relaxant property of lemongrass constituents.</p> <p>Clinical implication: such vasorelaxant activity could potentiate antihypertensive drugs and warrants blood-pressure monitoring when combining the herb with medication.</p> </ul>